Abstract: The present invention relates to highly stable drug dosage forms comprising. The invention also contemplates said highly stable drug dosage forms for the treatment of diseases where inhibition of 4-hydroxyphenylpyruvate dioxygenase 5 will result at improving the health of the patient.
Type:
Grant
Filed:
February 9, 2017
Date of Patent:
January 12, 2021
Assignee:
DIPHARMA S.A.
Inventors:
Chiara Conti, Salvatore Agostino Giammillari, Giuseppe Maccari
Abstract: The present invention relates to highly stable drug dosage forms comprising. The invention also contemplates said highly stable drug dosage forms for the treatment of diseases where inhibition of 4-hydroxyphenylpyruvate dioxygenase 5 will result at improving the health of the patient.
Type:
Application
Filed:
February 9, 2017
Publication date:
May 30, 2019
Applicant:
Dipharma S.A.
Inventors:
Chiara CONTI, Salvatore Agostino GIAMMILLARI, Giuseppe MACCARI
Abstract: The present invention relates to an improved synthesis and crystallization process of the 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitor 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione, also known as nitisinone or NTBC.
Abstract: The present invention relates to an improved synthesis and crystallization process of the 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitor 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione, also known as nitisinone or NTBC.
Abstract: The present invention relates to an improved synthesis and crystallization process of the 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitor 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione, also known as nitisinone or NTBC.
Abstract: The present invention relates to stable pharmaceutical compositions of tetrahydrobiopterin and processes for producing such compositions. Particularly the present invention relates to stable pharmaceutical compositions comprising tetrahydrobiopterin and at least one stabilizing agent.
Abstract: The invention relates to a novel process for the preparation of (R)-2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole, or a salt thereof.
Type:
Application
Filed:
April 19, 2012
Publication date:
October 4, 2012
Applicant:
Dipharma S.p.A.
Inventors:
Pietro ALLEGRINI, Gabriele Razzetti, Vittorio Lucchini
Abstract: A process for the purification of 1,4-butanediol mononitrate from 1,4-butanediol dinitrate and 1,4-butanediol, by selective extraction with solvents is herein disclosed.
Abstract: A process for the preparation of compounds of formula HO-A-ONO2??(I) wherein A is a C2-C6 alkylene chain by nitration of the corresponding alkanediols with “stabilized” nitric acid is herein disclosed. The process is safer to operators and allows to obtain advantageous yields on an industrial scale.
Abstract: The invention provides novel crystalline forms of fexofenadine hydrochloride, a process for the preparation of the novel forms and of the known form A, and their use in therapy.
Type:
Application
Filed:
October 28, 2008
Publication date:
April 30, 2009
Applicant:
DIPHARMA S.P.A.
Inventors:
Graziano CASTALDI, Giuseppe BARRECA, Pietro ALLEGRINI, Gianpiero VENTIMIGLIA
Abstract: A process for the purification of 1,4-butanediol mononitrate from 1,4-butanediol dinitrate and 1,4-butanediol, by selective extraction with solvents is herein disclosed.
Abstract: A novel process for the preparation of tolterodine, i.e. (R)—N, N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine, in the racemic form, as well as intermediates useful for its preparation.
Type:
Grant
Filed:
December 14, 2007
Date of Patent:
September 2, 2008
Assignee:
Dipharma S.p.A.
Inventors:
Gabriele Razzetti, Simone Mantegazza, Roberto Rossi, Pietro Allegrini
Abstract: A process for the preparation of compounds of formula HO-A-ONO2 ??(I) wherein A is a C2-C6 alkylene chain by nitration of the corresponding alkanediols with “stabilised” nitric acid is herein disclosed. The process is safer to operators and allows to obtain advantageous yields on an industrial scale.